This report identifies the Immunohistochemistry Market size in for the year 2015-2017 and forecast of the same for year 2022. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Immunohistochemistry Market.
Geographically North America dominated the Immunohistochemistry Market owing to well developed & established healthcare industry, higher spending on healthcare and higher awareness about cancer amongst its citizens. North America was followed by Europe and Asia-Pacific as the second and third largest markets for immunohistochemistry. However, it is estimated that Asia-Pacific will remain as the fastest growing market for immunohistochemistry during the period of study driven by infrastructural development in healthcare sector, growth in the geriatric population, increasing prevalence and awareness of cancer, growing access to medical facilities and growing disposable incomes in the emerging economies such as India, China and few others.
This report segments Immunohistochemistry Market on the basis of product, application, end user and regional market as follows:
On the basis of product this report on Immunohistochemistry Market is segmented as follows, covering all major product type in the immunohistochemistry as follows: Antibody, Equipment, Reagents and Kits
This report on immunohistochemistry also covers in detail various applications of immunohistochemistry, some of the major applications covered in the report are Diagnostics and Drug Testing
This report on immunohistochemistry also covers in detail major end users of immunohistochemistry, some of the major end users covered in the report are Hospitals and Diagnostic Laboratories, Research Institutes, Other End Users
This report on global immunohistochemistry also covers in detail various applications of immunohistochemistry, some of the major application covered in the report are Clinical documentation, E-Prescribing, Order entry (CPOE), Patient tracking, Resource tracking and management, Other applications
This report on immunohistochemistry has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets in each of the region
Sample companies profiled in this report are:
F. Hoffmann-LA Roche AG
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Immunohistochemistry Market– Forces
4.1.1. Growing awareness and registered cased of cancer
4.1.2. Rapidly growing geriatric population
4.1.3. Advancement in healthcare industry
4.2.1. Limited reimbursement
4.3.1. Developing healthcare infrastructure in Asian region
4.3.2. Increasing Demand for Personalized Medicine
4.4.1. Regulatory restrictions
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Immunohistochemistry Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life cycle Analysis
5.5. Suppliers & Distributors
6. Immunohistochemistry Market, By Product
6.1.1. Primary Antibodies
6.1.2. Secondary Antibodies
6.2.1. Slide Staining Systems
6.2.2. Tissue Microarrays
6.2.3. Tissue Processing Systems
6.2.4. Slide Scanners
6.2.5. Other Equipment
6.3.1. Histological Stains
6.3.2. Blocking Sera and Reagents
6.3.3. Chromogenic Substrates
6.3.4. Fixation Reagents
6.3.6. Organic Solvents
6.3.7. Proteolytic Enzymes
7. Immunohistochemistry Market, By Application
7.1.2. Infectious Diseases
7.1.3. Cardiovascular Disease
7.1.4. Autoimmune Diseases
7.1.5. Diabetes Mellitus
7.1.6. Nephrological Diseases
7.2. Drug Testing
8. Immunohistochemistry Market, By End User
8.1. Hospitals and Diagnostic Laboratories
8.2. Research Institutes
8.3. Other End Users
9. Immunohistochemistry Market, By Geography
9.1.7. Rest of Europe
9.2. Asia Pacific
9.2.4. South Korea
9.2.5. Rest of Asia-Pacific
9.3. North America
9.4. Rest of the World (RoW)
9.4.1. Middle East
9.4.2. South America
10. Immunohistochemistry – Market Entropy
10.2. Technological Developments
10.3. Merger & Acquisitions, and Joint Ventures
10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. F. Hoffmann-LA Roche AG
11.2. Danaher Corporation
11.3. Agilent Technologies, Inc.
11.4. Thermo Fisher Scientific Inc.
11.5. Merck Millipore
11.6. Bio-Rad Laboratories, Inc.
11.7. Perkinelmer, Inc.
11.8. Abcam PLC
11.9. Cell Signaling Technology, Inc.
11.10. Bio SB
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12.3. Research Methodology
12.5. Compilation of Expert Insights
- F. Hoffmann-LA Roche AG
- Danaher Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Merck Millipore
- Bio-Rad Laboratories, Inc.
- Perkinelmer, Inc.
- Abcam PLC
- Cell Signaling Technology, Inc.
- Bio SB